Financial News
bluebird bio, Inc. - Common Stock (NQ:BLUE)
All News about bluebird bio, Inc. - Common Stock



Via Benzinga


(BLUE) - Analyzing bluebird bio's Short Interest
February 29, 2024
Via Benzinga







Is CRISPR Therapeutics the NVIDIA of gene editing?
February 26, 2024
Via MarketBeat
Topics
Artificial Intelligence



Gene Therapy For Beta-Thalassemia: CRISPR Therapeutics/Vertex's Casgevy Secures FDA Nod Ahead of Schedule
January 17, 2024
Via Benzinga
Exposures
Product Safety

2 Red Flags for Bluebird Bio Stock
January 10, 2024
Via The Motley Fool




From bluebird bio, Inc.
Via Business Wire






12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 21, 2023
Via Benzinga

S&P 500 Edges Lower; General Mills Cuts Sales Forecast
December 20, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities


12 Health Care Stocks Moving In Wednesday's Intraday Session
December 20, 2023
Via Benzinga

Crude Oil Rises 1%; US Current Account Gap Narrows In Q3
December 20, 2023
Via Benzinga
Topics
Stocks
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.